Page 5 - Brain Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brain therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brain Therapeutics Today - Breaking & Trending Today

A Network And Pivot Model For Success In Cancer Drug Development

When CEO Avanish Vellanki founded and incorporated Rain Therapeutics on his living room couch in the spring of 2017, there was no drug in. ....

Avanish Vellanki , Ben Comer , Chief Editor , Life Science , Brain Therapeutics ,

Rain Therapeutics (NASDAQ:RAIN) Research Coverage Started at Roth Capital

Roth Capital started coverage on shares of Rain Therapeutics (NASDAQ:RAIN – Get Rating) in a research note issued on Thursday, The Fly reports. The firm set a “buy” rating on the stock. A number of other brokerages have also commented on RAIN. Piper Sandler decreased their price objective on Rain Therapeutics from $26.00 to $12.00 […] ....

United States , Piper Sandler , Geode Capital Management , Rain Therapeutics Inc , Goldman Sachs Group Inc , Blackrock Inc , Deutsche Bank , Roth Capital , Brain Therapeutics , Get Rating , Capital Management , Sachs Group , Therapeutics Inc , Nasdaq Rain , Initiated Coverage ,